,Recent headlines and conversations for JNJ,Polarity
0,JNJ targets COVID-19 late-stage trial results by January,0.6427
1,"Biden to meet on with CEOs of JNJ, Merck at White House on Wednesday: official",-0.0866
2,BRIEF-Genscript Biotech Updates On Phase 1B/2 Cartitude-1 Study Evaluating JNJ-68284528,0.4886
3,J&J (JNJ) COVID-19 Vaccine Gets WHO's Emergency Listing,0.5363
4,J&J (JNJ) COVID-19 Vaccine Gets Conditional Approval in Europe,0.8414
5,J&J (JNJ) Outperforms the Industry Year to Date: Here's Why,0.5111
6,BRIEF-Janssen's BCMA CAR-T Therapy JNJ-4528 Showed Early Responses In Heavily Pretreated Patients With Multiple Myeloma,0.5763
7,BRIEF-Illinois State Treasurer's Office Urges JNJ Shareholders To Vote For Two Proposals,0.5535
8,"Trump suggests Pfizer could win U.S. COVID-19 vaccine approval, JNJ to come later",0.9107
9,This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock,0.604
10,Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know,-0.2213
11,BRIEF-Medivir: Janssen discontinues development of JNJ-4178 for hepatitis C,0.3125
12,"Biden to meet on with CEOs of JNJ, Merck at White House on Wednesday -official",-0.0866
